2020
DOI: 10.1002/14651858.cd006212.pub5
|View full text |Cite
|
Sign up to set email alerts
|

Vena caval filters for the prevention of pulmonary embolism

Abstract: a This population was reported by PREPIC2. All participants also received anticoagulation. b We downgraded certainty by one step due to some imprecision and risk of bias concerns (low numbers of events and open-label study design). c Major bleeding was defined as bleeding that contributed to death; occurred at a critical site (e.g. intracranial, intraspinal, epidural, or lung haemorrhage); led to transfusion of 2 or more units of red cells, platelets, or fresh frozen plasma; or was associated with a decrease … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
16
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 19 publications
(16 citation statements)
references
References 60 publications
0
16
0
Order By: Relevance
“…Recently, a Cochrane systematic review concluded, of the six identified randomized studies, one did not show significant evidence in the placement of an IVCF in the first three months regarding PE, DVT, severe bleeding, and mortality, and another study also showed no benefit in PE and mortality for patients with prophylactic IVCF placement in polytraumatized patients. The remaining four studies presented no firm conclusions regarding filter efficacy in the prevention of PE, suggesting the necessity of further trials to determine the efficacy of IVCFs [ 42 ].…”
Section: Resultsmentioning
confidence: 99%
“…Recently, a Cochrane systematic review concluded, of the six identified randomized studies, one did not show significant evidence in the placement of an IVCF in the first three months regarding PE, DVT, severe bleeding, and mortality, and another study also showed no benefit in PE and mortality for patients with prophylactic IVCF placement in polytraumatized patients. The remaining four studies presented no firm conclusions regarding filter efficacy in the prevention of PE, suggesting the necessity of further trials to determine the efficacy of IVCFs [ 42 ].…”
Section: Resultsmentioning
confidence: 99%
“…In 2006, the British Committee for Standards in Haematology concluded that no particular IVCF design had proven superiority, but that removable filters should be used [53]. A Cochrane review in 2010 [54] documented that only two randomised controlled trials (RCTs) fulfilled the inclusion criteria [55,56] and that, although there were large case series reporting long-term experience of IVCFs for various indications, none of which included UHRAPs, no firm judgements could be made and no recommendations given for other subgroups of patients, as they had not been studied in any RCTs. In accordance with other studies, it was concluded that large RCTs, of at least two years duration, were required to investigate the indications for IVCFs in high-risk patients, the timing of insertion and removal, short and long-term complications and a comparison of permanent versus retrievable filters, including subgroup analyses of various filter brands [26,32,38,40,45,52].…”
Section: Discussionmentioning
confidence: 99%
“…It is well known that implantation of IVC filter is effective in the prevention or reduction of the risk of fatal PE in patients with high risk of lower extremity deep vein thrombosis ( 12 ). In rare cases, some IVC filters have also been used as a prevention strategy against cement emboli in IVC, which may migrate into the pulmonary circulation ( 13 , 14 ).…”
Section: Discussionmentioning
confidence: 99%